Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
30th Jun 16 Source: CRO
- €5 billion turnover
- 13,300 employees
-
27th Jun 15 Source: CRO
- €4 billion turnover
-
€217.9 million
profit - 13,000 employees
- 2 more years available »
Ranking
By Turnover
(€5 billion)- 19th in Top Companies
- 5th in Health
- 3rd in Pharma
By Employees
(13,300)- 13th in Top Companies
- 2nd in Health
- 2nd in Pharma
-
- 13,300
- €5 billion
Employees
- John Hendrickson CEO/Managing Director